In January, specialty pharmacy group contracting organization Armada Health Care introduced ApproveRx, a Web-based system that it says will greatly streamline the prior authorization process and already has been adopted by Amber Pharmacy. Meanwhile, the company also is gearing up for the Armada Summit at the Wynn Las Vegas Hotel in May. Recently, Drug Store News spoke with Armada CEO Larry Irene about these recent developments.
Personal care company Kimberly-Clark, whose portfolio includes Kotex, has announced executive changes designed to further enhance its focus on executing its global business plan and driving global expansion.
Global consumer confidence held steady at an index of 94 for three consecutive quarters, ending 2013 one point higher than it started and three points higher than the same time period the previous year, according to consumer confidence findings released by Nielsen.
Whether it is rose hip seed oil, Argan oil, jojoba oil, olive oil or Kukui oil, incorporating oil into a skin care regimen is the buzz, and it is likely that the segment will gain even greater attention during 2014.
The natural personal care market continues to see strong growth, posting healthy double-digit gains globally with Brazil and China taking the lead as the fastest-growing natural personal care markets, according to consulting and research firm Kline & Co.
Men’s fragrance juice sales at prestige drove positive dollar performance for the overall fragrance category in the United States and United Kingdom between November 2012 and October 2013, according to research by The NPD Group.
The number of patients receiving prescriptions for statins is expected to increase modestly following new cholesterol recommendations from the American College of Cardiology and the American Heart Association, according to a new report.
Procter & Gamble has announced a string of organization changes, including the retirement of 37-year company veteran Dimitri Panayotopoulos, vice chairman and adviser to the chairman and CEO, effective Jan. 2, 2014.
Skin care brand Beiersdorf reported that its consumer business segment achieved “significant, above-market sales growth” during the first nine months of 2013, with both Nivea and Eucerin enjoying a boost in sales.
When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.
Nearly all doctors say that the sharp growth in Type 2 diabetes around the world and the obesity epidemic are linked to excess sugar consumption, according to a new report by the Credit Suisse Research Institute.
European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.